Inhaled bispecific single-domain antibody BM219 for mild-to-moderate COVID-19: a double-blind, randomized, placebo-controlled phase 2 trial

Inhaled bispecific single-domain antibody BM219 for mild-to-moderate COVID-19: a double-blind, randomized, placebo-controlled phase 2 trial

Saved in:

Bibliographic Details
Main Authors:	Yanling Wu, Yuan Li, Ping Zhang, Siwei Guo, Fang Yuan, Vivian Liu, Ting Yu, Feng Lin, Nan Yang, Chao Tu, Hongzhou Lu, Tianlei Ying, Xin Li
Format:	Article
Language:	English
Published:	Nature Publishing Group 2025-07-01
Series:	Cell Discovery
Online Access:	https://doi.org/10.1038/s41421-025-00813-0
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

280–300 GHz SiGe‐InP hybrid‐integrated transmitter with 21.9 dBm EIRP and 10 Gbps data rate
by: Haiyan Lu, et al.
Published: (2024-12-01)

Bispecific engineered antibody domains (nanoantibodies) that interact noncompetitively with an HIV-1 neutralizing epitope and FcRn.
by: Rui Gong, et al.
Published: (2012-01-01)

EFFICACY AND TOLERABILITY OF LERCANIDIPINE IN ELDERLY PATIENTS WITH MILD TO MODERATE HYPERTENSION IN A PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY
by: M. A. Ninci, et al.
Published: (2016-01-01)

A randomized, double-blind, placebo-controlled trial of niclosamide nanohybrid for the treatment of patients with mild to moderate COVID-19
by: Jung Ho Kim, et al.
Published: (2025-08-01)

Clinics in diagnostic imaging (219)
by: Jingli Chong, et al.
Published: (2024-04-01)

Comparison of intravenous nalbuphine and dexmedetomidine in combination with lidocaine aerosol inhalation in awake direct laryngoscopy: a randomized, double-blind, placebo-controlled trial
by: Xingxing Li, et al.
Published: (2024-10-01)

Cost-effectiveness analysis of aducanumab versus placebo for patients with mild cognitive impairment and mild Alzheimer’s disease
by: Minghui Li, et al.
Published: (2025-04-01)

Efficacy of WuSheZhiYang Pills in Mild-to-Moderate Atopic Dermatitis: Protocol for a Double-Blind, Randomized, Placebo-Controlled Trial
by: Xiangjin Gao, et al.
Published: (2025-07-01)

Inhaled beclomethasone in the treatment of early COVID-19: a double-blind, placebo-controlled, randomised, hospital-based trial in Sri Lanka
by: Chamila Mettananda, et al.
Published: (2023-12-01)

Efficacy and safety of butylphthalide in patients with mild cognitive impairment: a multicentre, randomised, double-blind, placebo-controlled trial (EBMCI study)
by: Pin Wang, et al.
Published: (2024-07-01)

Exhalation of Rn-219 by patients treated with Radium-223
by: Carsten Wanke, et al.
Published: (2025-01-01)

Effectiveness and safety of Chinese herbal acupoint application in adult patients with fever and mild-to-moderate COVID-19: a multicenter, randomized, double-blind, placebo-controlled trial
by: Yicheng Liu, et al.
Published: (2025-06-01)

Efficacy and safety of inhaled ambroxol hydrochloride solution in patients with lower respiratory tract infectious diseases: a randomized, double-blind, placebo-controlled, multicentre clinical trial
by: Di Wu, et al.
Published: (2025-07-01)

A 24‐week double‐blind placebo‐controlled study of the efficacy and safety of the AMPA modulator S47445 in patients with mild to moderate Alzheimer's disease and depressive symptoms
by: Katy Bernard, et al.
Published: (2019-01-01)

Evidence of Improvements to Arterial Stiffness Among Regular Users of Combustible Cigarettes – Effect of Inhalation of β-Caryophyllene: A Randomized, Double-Blind, Placebo-Controlled Study
by: Yamada Kazuya, et al.
Published: (2025-07-01)

Efficacy and safety of inhaled ambroxol solution in improving sputum of lower respiratory tract infection in children: a multicenter, randomized, double-blind, placebo-controlled trial
by: Baoping Xu, et al.
Published: (2025-08-01)

Low-cost CMOS BM-TIA Design for PON
by: ZHAO Wanqing, et al.
Published: (2025-02-01)

Efficacy and Safety of Haidebao Body Lotion in Patients With Mild Atopic Dermatitis: Protocol for a Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial
by: Zhen Duan, et al.
Published: (2025-06-01)

Broadening sarbecovirus neutralization with bispecific antibodies combining distinct conserved targets on the receptor binding domain
by: Denise Guerra, et al.
Published: (2024-12-01)

Safety, tolerability, and efficacy of intranasally-administered detoxified LTh(αK) in mild-to-moderate COVID-19 patients: A randomized, double-blinded, placebo-controlled phase 2 study
by: Chien-Yu Cheng, et al.
Published: (2024-12-01)

Effect of heat-killed Lacticaseibacillus paracasei KW3110 on mild to moderate seasonal allergic rhinitis symptoms in Japanese adults: a randomized, double-blind, placebo-controlled parallel-group study
by: Yoshihiko Sugihara, et al.
Published: (2025-06-01)

Double-blind clonazepam vs placebo in panic disorder treatment
by: ALEXANDRE MARTINS VALENÇA, et al.
Published: (2000-12-01)

Virtues in Plotinus: The Theory of Purification and Assimilation (to God) in the Enneads (I,2,19)
by: Cahid Şenel
Published: (2023-12-01)

MicroRNA-219 in the central nervous system: a potential theranostic approach
by: Nahal Shamaeizadeh, et al.
Published: (2024-12-01)

Safety and Efficacy of Ephedrine Alkaloids-Free Ephedra Herb Extract (EFE) for Mild COVID-19: A Double-Blind, Placebo-Controlled, Randomized Comparative Trial
by: Hiroshi Odaguchi, et al.
Published: (2025-03-01)

The state of the art of bispecific antibodies for treating human malignancies
by: Shuhang Wang, et al.
Published: (2021-08-01)

A randomized, double-blind, Phase 1, single- and multiple-dose placebo-controlled study of the safety and pharmacokinetics of IN-006, an inhaled antibody treatment for COVID-19 in healthy volunteersResearch in context
by: Thomas R. Moench, et al.
Published: (2025-03-01)

Efficacy and safety of SHEN26, a novel oral small molecular RdRp inhibitor for COVID-19 treatment: a multicenter, randomized, double-blinded, placebo-controlled, phase II clinical trial
by: Jiangtao Bai, et al.
Published: (2025-01-01)

Automatisation developments on ESRF-EBS BM05 beamline
by: Fabien Léonard, et al.
Published: (2025-02-01)

Breeding of Common Bukovinian and Moldavian (BM) Maize Hybrids
by: А. М. Черномиз, et al.
Published: (2009-10-01)

Efficacy and safety of Kunxinning granules in patients with menopausal syndrome: a multicenter, randomized, double-blinded, and placebo-controlled trial
by: Guirong Zhou, et al.
Published: (2025-07-01)

Metformin for low back pain: Study protocol for a randomised, double-blind, placebo-controlled trial
by: Yuan Z. Lim, et al.
Published: (2025-03-01)

Metformin for knee osteoarthritis with obesity: study protocol for a randomised, double-blind, placebo-controlled trial
by: Yuanyuan Wang, et al.
Published: (2023-12-01)

Double-Blind, Placebo-Controlled Study of Myotoxicity and Neurotoxicity of Bupivacaine in Rats
by: R. E. Lakhin, et al.
Published: (2019-11-01)

Differential expression and subcellular localization of BmHMGA in silkworm (Bombyx mori)
by: Zhang Haihua, et al.
Published: (2014-05-01)

Real-world use of inhaled corticosteroid/formoterol as needed in adults with mild asthma: the PRIME study
by: Guy Brusselle, et al.
Published: (2024-09-01)

Efficacy of Hibiscus sabdariffa L. extract on metabolic parameters in participants with abdominal obesity and mild metabolic syndrome in Bangkok, Thailand: A double-blind, randomized, placebo-controlled trial
by: Kanchaporn Chaisungnern, et al.
Published: (2025-08-01)

<i>Bombyx mori</i> RPL12 Participates in UV-Induced DNA Damage Repair and Interacts with BmNPV Bm65 Protein Only After Ultraviolet Radiation
by: Qi Tang, et al.
Published: (2025-02-01)

The Effect of Cuscuta chinensis on Mild to Moderate Depression: a Double-Blind Randomized Clinical Trial
by: Roshanak Mokaberinejad, et al.
Published: (2025-04-01)

CRF combined with ShapeBM shape priors for image labeling
by: Hao WANG, et al.
Published: (2017-01-01)